Martin Stenström

Active Biotech (Sweden) — Sweden

Immunology and Microbiology · Life Sciences

11h-index825citations21works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(7), Immune Cell Function and Interaction(6), Immune Response and Inflammation(5), Immunotherapy and Immune Responses(4), S100 Proteins and Annexins(4)

Publications21 total

Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis
Journal of Dermatological Science·2016· 49 citedOpen Access
FRI0496 An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis (SSC) Patients Treated with Paquinimod (ABR-215757)
Annals of the Rheumatic Diseases·2014· 3 cited
FRI0516 Paquinimod (ABR-215757), an Immunomodulatory Compound, Reduces Fibrosis in the Tight Skin-1 (TSK-1) Model for Systemic Sclerosis
Annals of the Rheumatic Diseases·2014· 1 cited
Abstract B78: Immunomodulation by tasquinimod: Skewing of tumor infiltrating myeloid cell populations.
Cancer Research·2013
Abstract B17: Immunomodulation by tasquinimod: Combination with immunotherapy results in enhanced CD8 T cell responses and improved antitumor effects.
Cancer Research·2013· 1 cited
CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden
BMC Immunology·2012· 33 citedOpen Access
Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
Arthritis Research & Therapy·2011· 60 citedOpen Access
Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: Block of initiation of proliferation of Gr-1+ cells
International Immunopharmacology·2011· 4 citedOpen Access
Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757
International Immunopharmacology·2010· 6 cited
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
PLoS Biology·2009· 354 citedOpen Access
Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets
Molecular Immunology·2008· 38 cited
Natural killer T‐cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice—a novel thymic subset defined in BALB.NK mice
Immunology·2005· 22 citedOpen Access
Natural killer T cell subsets and regulation of autoimmune diabetes
Lund University Publications (Lund University)·2005Open Access
Prevention of Diabetes in Nonobese Diabetic Mice Mediated by CD1d-Restricted Nonclassical NKT Cells
The Journal of Immunology·2004· 102 cited
Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase
Journal of Biotechnology·2004· 35 cited
Kommunikationsflödet i ett förändringsprojekt : de anställdas arbetsmotivation, samt deras attityd till arbetsplatsen
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2004Open Access
Surface receptors identify mouse NK1.1<sup>+</sup> T cell subsets distinguished by function and T cell receptor type
European Journal of Immunology·2003· 41 citedOpen Access
MHC‐dependent and ‐independent modulation of endogenous Ly49 receptors on NK1.1<sup>+</sup> T lymphocytes directed by T‐cell receptor type
Immunology·2003· 21 citedOpen Access
Electrical Impedance of Nodular Basal Cell Carcinoma: A Pilot Study
Dermatology·1998· 55 cited
Subject Index
Dermatology·1998Open Access
page 1 of 2Next →

Frequent Co-authors

Tomas Leanderson(8), Susanna Cardell(6), David Liberg(5), Fredrik Ivars(5), Marie Törngren(5), Helena Eriksson(5), Anders Olsson(3), Ingrid Nicander(3), Stig Ollmar(3), Helén Nyhlén(3), Birgitta Sparre(3), Helén Tuvesson(3), Markus Sköld(3), Eva Källberg(2), Stéphane Sidobre(2), Mitchell Kronenberg(2), Oliver Distler(2), Rika Chikama(2), Masakiyo Hosokawa(2), Tetsuya Miyazawa(2)